Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
28.00
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Profit Margin (Quarterly): -43.38K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.47% |
| Axonics Inc (DELISTED) | -0.02% |
| Harpoon Therapeutics Inc (DELISTED) | -40.51% |
| Merck & Co., Inc. | 33.68% |
| RayzeBio inc (DELISTED) | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.85% |
| Return on Assets | -29.51% |
| Return on Invested Capital | -33.81% |
| Operating Margin (Quarterly) | -48.35K% |
| Return on Net Operating Assets | -153.7% |